APOPS FoUNDER SHERRIE PALM
Sherrie Palm is the Founder/CEO/Executive Director of Association for Pelvic Organ Prolapse Support (APOPS), a pelvic organ prolapse (POP) Key Opinion Leader, author of award winning book Pelvic Organ Prolapse: The Silent Epidemic, a speaker on multiple aspects of pelvic organ prolapse quality of life impact, and an international women's pelvic health advocate. Sherrie’s points of focus are generating global POP awareness, developing guidance and support structures for women navigating POP, and bridge building within POP healthcare, research, academia, industry, and policy sectors toward the evolution of POP directives.
Sherrie Palm's journey began in December 2007, with her diagnosis of pelvic organ prolapse. Upon returning home and researching POP, she discovered how common the condition is, that it had been medically documented for nearly 4000 years, and that stigma continued to shroud the condition in silence. In an effort to increase awareness of pelvic organ prolapse, Sherrie wrote the first edition of Pelvic Organ Prolapse: The Silent Epidemic, which was published in in April 2009. While marketing that edition, Sherrie recognized the most effective way to reach women to educate them about pelvic organ prolapse was to found a nonprofit, and APOPS became a federally recognized 501(c)(3) nonprofit agency. Information on the 3rd edition is available here.
Contact Sherrie Palm regarding presenting at your event via APOPS landline at 262-642-4338; additional contact info available on Speaker Onesheet.
Misconceptions abound in the field of pelvic organ prolapse. To advance POP understanding, we must clarify the reality of impact to quality of life to enable clinicians to recognize misconceptions. Diagnostic clinicians are currently poorly educated about pelvic organ prolapse. Despite childbirth and menopause being the leading causes of POP, women are currently not screened for the condition during routine pelvic exams.
It is imperative all sectors engaged in the POP arena bridge together to recognize, evaluate, and address pelvic organ prolapse. Industry develops both surgical and non-surgical treatments, and it is imperative they understand the needs of women navigating pelvic organ prolapse.
Policy is a key aspect of the evolution of POP awareness, diagnosis, treatment, and research. Representing the needs of women at legislative priority meetings is a pivotal aspect of generating much needed evolution in all aspects of pelvic organ prolapse diagnostics and treatment.